Efficacy and Safety of Dahuang Zhechong Pill in Silicosis: A Randomized Controlled Trial
Background. There is no effective therapy for silicosis, and Dahuang Zhechong pill (DHZCP), an ancient Chinese medicine prescription, may have a therapeutic effect on silicosis. This study aims to verify the efficacy and safety of DHZCP in silicosis. Methods. This is a randomized controlled clinical...
Guardado en:
Autores principales: | Wu-Yi-Nuo Tang, Jing-Tao Liang, Ju Wu, Li Liu, Ming-Zhang Lu, Xiao-Yan He, Li-Juan Wu, Huan-Yu Jiang, Fei Wang, Xiao Meng, Shun-Pin Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d22b6dcaee547b6b94cee6218d7580a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploring the Effect of Jiawei Buguzhi Pills on TGF-β-Smad Pathway in Postmenopausal Osteoporosis Based on Integrated Pharmacological Strategy
por: Xiao Yuan, et al.
Publicado: (2021) -
Tibetan Medicine Qishiwei Zhenzhu Pills Can Reduce Cerebral Ischemia-Reperfusion Injury by Regulating Gut Microbiota and Inhibiting Inflammation
por: Ke Fu, et al.
Publicado: (2021) -
Efficacy and Safety of Chinese Medicine in Treating Arrhythmia: Meta-Analysis of Randomized Controlled Trials
por: Hanyu He, et al.
Publicado: (2021) -
Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
por: Zongliang Yu, et al.
Publicado: (2021) -
Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice
por: Huanhuan Zhang, et al.
Publicado: (2021)